Assessment of the efficacy and toxicity of (131)I-metaiodobenzylguanidine therapy for metastatic neuroendocrine tumours

por Nwosu, A C, Jones, L, Vora, J, Poston, G J, Vinjamuri, S, Pritchard, D M
Publicado 2008

The E3 ubiquitin ligase EDD is an adverse prognostic factor for serous epithelial ovarian cancer and modulates cisplatin resistance in vitro

por O'Brien, P M, Davies, M J, Scurry, J P, Smith, A N, Barton, C A, Henderson, M J, Saunders, D N, Gloss, B S, Patterson, K I, Clancy, J L, Heinzelmann-Schwarz, V A, Scolyer, R A, Zeng, Y, Williams, E D, Scurr, L, DeFazio, A, Quinn, D I, Watts, C K W, Hacker, N F, Henshall, S M, Sutherland, R L
Publicado 2008

HLA-associated susceptibility to childhood B-cell precursor ALL: definition and role of HLA-DPB1 supertypes

por Taylor, G M, Hussain, A, Lightfoot, T J, Birch, J M, Eden, T O B, Greaves, M F
Publicado 2008

Phase II study of capecitabine and oxaliplatin given prior to and concurrently with preoperative pelvic radiotherapy in patients with locally advanced rectal cancer

por Koeberle, D, Burkhard, R, von Moos, R, Winterhalder, R, Hess, V, Heitzmann, F, Ruhstaller, T, Terraciano, L, Neuweiler, J, Bieri, G, Rust, C, Toepfer, M
Publicado 2008

Involvement of focal adhesion kinase in cellular invasion of head and neck squamous cell carcinomas via regulation of MMP-2 expression

por Canel, M, Secades, P, Garzón-Arango, M, Allonca, E, Suarez, C, Serrels, A, Frame, M C, Brunton, V, Chiara, M-D
Publicado 2008

Urological referral of asymptomatic men in general practice in England

por Melia, J, Coulson, P, Coleman, D, Moss, S
Publicado 2008

Cyclopentenyl cytosine increases gemcitabine radiosensitisation in human pancreatic cancer cells

por van Bree, C, Rodermond, H M, Leen, R, Medema, J P, van Kuilenburg, A B P
Publicado 2008

The treatment and outcomes of early-stage epithelial ovarian cancer: have we made any progress?

por Chan, J K, Fuh, K, Shin, J Y, Cheung, M K, Powell, C B, Chen, L-m, Kapp, D S, Osann, K
Publicado 2008

Surveillance of cirrhosis for hepatocellular carcinoma: a cost–utility analysis

por Thompson Coon, J, Rogers, G, Hewson, P, Wright, D, Anderson, R, Jackson, S, Ryder, S, Cramp, M, Stein, K
Publicado 2008

Infiltrating regulatory T cell numbers is not a factor to predict patient's survival in oesophageal squamous cell carcinoma

por Yoshioka, T, Miyamoto, M, Cho, Y, Ishikawa, K, Tsuchikawa, T, Kadoya, M, Li, L, Mishra, R, Ichinokawa, K, Shoji, Y, Matsumura, Y, Shichinohe, T, Hirano, S, Shinohara, T, Itoh, T, Kondo, S
Publicado 2008

Targeted killing of colorectal cancer cell lines by a humanised IgG1 monoclonal antibody that binds to membrane-bound carcinoembryonic antigen

por Conaghan, P J, Ashraf, S Q, Tytherleigh, M G, Wilding, J L, Tchilian, E, Bicknell, D, Mortensen, N JMcC, Bodmer, W F
Publicado 2008

Prospective study of serum 25(OH)-vitamin D concentration and risk of oesophageal and gastric cancers

por Chen, W, Dawsey, S M, Qiao, Y-L, Mark, S D, Dong, Z-W, Taylor, P R, Zhao, P, Abnet, C C
Publicado 2007

Circulating insulin-like growth factor axis and the risk of pancreatic cancer in four prospective cohorts

por Wolpin, B M, Michaud, D S, Giovannucci, E L, Schernhammer, E S, Stampfer, M J, Manson, J E, Cochrane, B B, Rohan, T E, Ma, J, Pollak, M N, Fuchs, C S
Publicado 2007

The significance of proline-rich tyrosine kinase2 (Pyk2) on hepatocellular carcinoma progression and recurrence

por Sun, C K, Ng, K T, Sun, B S, Ho, J W Y, Lee, T K, Ng, I, Poon, R T P, Lo, C M, Liu, C L, Man, K, Fan, S T
Publicado 2007

Outcome of a risk-related therapeutic strategy used prospectively in a population-based study of Hodgkin's lymphoma in adolescents

por Jones, G L, Taylor, P R A, Windebank, K P, Hoye, N A, Lucraft, H, Wood, K, Angus, B, Proctor, S J
Publicado 2007

Quality of life after curative gastrectomy for gastric cancer in a randomised controlled trial

por Wu, C-W, Chiou, J-M, Ko, F-S, Lo, S-S, Chen, J-H, Lui, W-Y, Whang-Peng, J
Publicado 2008

Methotrexate, vinblastine, doxorubicin and cisplatin combination regimen as salvage chemotherapy for patients with advanced or metastatic transitional cell carcinoma after failure...

por Han, K S, Joung, J Y, Kim, T S, Jeong, I G, Seo, H K, Chung, J, Lee, K H
Publicado 2008

Quality of life and quality-adjusted survival (Q-TWiST) in patients receiving dose-intensive or standard dose chemotherapy for high-risk primary breast cancer

por Bernhard, J, Zahrieh, D, Zhang, J J, Martinelli, G, Basser, R, Hürny, C, Forbes, J F, Aebi, S, Yeo, W, Thürlimann, B, Green, M D, Colleoni, M, Gelber, R D, Castiglione-Gertsch, M, Price, K N, Goldhirsch, A, Coates, A S
Publicado 2008

Biological predictive factors in rectal cancer treated with preoperative radiotherapy or radiochemotherapy

por Negri, F V, Campanini, N, Camisa, R, Pucci, F, Bui, S, Ceccon, G, Martinelli, R, Fumagalli, M, Losardo, P L, Crafa, P, Bordi, C, Cascinu, S, Ardizzoni, A
Publicado 2008

A combination of gefitinib and FOLFOX-4 as first-line treatment in advanced colorectal cancer patients. A GISCAD multicentre phase II study including a biological analysis of EGFR...

por Cascinu, S, Berardi, R, Salvagni, S, Beretta, G D, Catalano, V, Pucci, F, Sobrero, A, Tagliaferri, P, Labianca, R, Scartozzi, M, Crocicchio, F, Mari, E, Ardizzoni, A
Publicado 2008